相似文献
1
Intra-arterial Chemotherapy in Patients With Metastatic Breast Cancer: A Scoping Review.
Cureus. 2024 Apr 23;16(4):e58846. doi: 10.7759/cureus.58846. eCollection 2024 Apr.
2
Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials.
PLoS One. 2012;7(7):e40847. doi: 10.1371/journal.pone.0040847. Epub 2012 Jul 18.
3
Regional intra-arterial vs. systemic chemotherapy for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis.
Front Oncol. 2024 Apr 8;14:1197424. doi: 10.3389/fonc.2024.1197424. eCollection 2024.
4
Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma.
Chin Med J (Engl). 2009 Feb 5;122(3):284-90.
5
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
Expert Opin Investig Drugs. 1997 Dec;6(12):1853-65. doi: 10.1517/13543784.6.12.1853.
6
Hepatic Arterial Infusion Chemotherapy for Metastatic Breast Cancer Patients With Resistance to Standard Systemic Chemotherapies.
In Vivo. 2020 Jan-Feb;34(1):275-282. doi: 10.21873/invivo.11771.
7
Overview of resistance to systemic therapy in patients with breast cancer.
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
8
Intra-arterial Chemotherapy in Patients With Metastatic or Locally Aggressive Pancreatic Adenocarcinoma: A Scoping Review.
Cureus. 2024 May 20;16(5):e60696. doi: 10.7759/cureus.60696. eCollection 2024 May.
9
Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel.
Oncotarget. 2017 Dec 31;9(8):8197-8203. doi: 10.18632/oncotarget.23793. eCollection 2018 Jan 30.
10
Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy.
Oncol Lett. 2018 Jul;16(1):1253-1258. doi: 10.3892/ol.2018.8701. Epub 2018 May 11.
引用本文的文献
1
TACE Versus TARE in the Treatment of Liver-Metastatic Breast Cancer: A Systematic Review.
Tomography. 2025 Jul 12;11(7):81. doi: 10.3390/tomography11070081.
2
How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years?
Hum Vaccin Immunother. 2025 Dec;21(1):2505349. doi: 10.1080/21645515.2025.2505349. Epub 2025 May 26.
本文引用的文献
1
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and A.
JCO Glob Oncol. 2024 Jan;10:e2300411. doi: 10.1200/GO.23.00411.
2
Breast Cancer Metastasis: Mechanisms and Therapeutic Implications.
Int J Mol Sci. 2022 Jun 18;23(12):6806. doi: 10.3390/ijms23126806.
3
Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival.
ESMO Open. 2022 Apr;7(2):100409. doi: 10.1016/j.esmoop.2022.100409. Epub 2022 Feb 26.
4
The Metabolic Mechanisms of Breast Cancer Metastasis.
Front Oncol. 2021 Jan 7;10:602416. doi: 10.3389/fonc.2020.602416. eCollection 2020.
5
Therapeutic Options for Metastatic Breast Cancer.
Adv Exp Med Biol. 2019;1152:131-172. doi: 10.1007/978-3-030-20301-6_8.
6
Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel.
Oncotarget. 2017 Dec 31;9(8):8197-8203. doi: 10.18632/oncotarget.23793. eCollection 2018 Jan 30.
7
Metastatic Breast Cancer.
Radiol Technol. 2017 May;88(5):519M-539M.
8
Clinical efficacy of local targeted chemotherapy for triple-negative breast cancer.
Radiol Oncol. 2011 Jun;45(2):123-8. doi: 10.2478/v10019-011-0014-7. Epub 2011 Apr 23.
9
Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancer.
Breast. 2012 Aug;21(4):556-61. doi: 10.1016/j.breast.2012.05.003. Epub 2012 Jun 4.
10
Chemotherapy for metastatic breast cancer.
Hematol Oncol Clin North Am. 2007 Apr;21(2):257-72. doi: 10.1016/j.hoc.2007.03.001.
Zotero 插件